This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Pono Corporation, University of Hawai'i. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: The Innovations of Andre S. Bachmann
Introduction
Andre S. Bachmann is a notable inventor based in Waipahu, HI (US). He has made significant contributions to the field of medical treatments, particularly in addressing tumors associated with N-MYC, c-MYC, and L-MYC amplification. With a total of 2 patents, his work has the potential to impact cancer therapies significantly.
Latest Patents
Bachmann's latest patents include a treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors. This invention focuses on methods and compositions for treating diseases through the administration of multiple drugs. Specific embodiments of this invention relate to neuroblastomas and other tumors, involving therapeutic compounds such as DFMO, SAM486A, a verinoid, and a cytotoxic drug, alongside dietary modifications. His second patent involves pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition, utilizing a syrbactin compound with specific structural formulas.
Career Highlights
Throughout his career, Andre S. Bachmann has worked with esteemed institutions, including the University of Hawai'i and Pono Corporation. His innovative approaches and research have contributed to advancements in cancer treatment methodologies.
Collaborations
Bachmann has collaborated with notable individuals in his field, including Robert Dudler and Michael Groll. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Andre S. Bachmann's contributions to medical innovation, particularly in cancer treatment, highlight his role as a significant inventor. His patents reflect a commitment to improving therapeutic strategies for challenging diseases.